LEADER 01971nam 2200361 450 001 9910688330003321 005 20230624150409.0 035 $a(CKB)5400000000043436 035 $a(NjHacI)995400000000043436 035 $a(EXLCZ)995400000000043436 100 $a20230624d2020 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDiseases of Pleura /$fedited by Jelena Stojs?ic? 210 1$aLondon :$cIntechOpen,$d2020. 210 4$dİ2020 215 $a1 online resource (94 pages) 311 $a1-78985-467-9 320 $aIncludes bibliographical references and index. 330 $aPleural diseases are usually accompanied by pulmonary or nonpulmonary (heart, kidney, thyroid, systemic) diseases. Rarely, pleural diseases are solitary lesions. Pleural effusions are frequent manifestations of pleural diseases. Their treatment depends on the cause of effusion. Tuberculous and nontuberculous inflammation of pleura cause effusion as well as benign and malignant tumors. Talc treatment is one of the modalities of therapy for pleural effusions. Asbestosis is still the leading cause of pleural tumors. A solitary fibrous tumor of pleura is a mesenchymal tumor with various morphological patterns but with a consistent immunophenotype. A high proliferative index requires frequent follow-up because of possibe relapse and mandatory oncological treatment. A pleural malignant mesothelioma is aggressive and is the most frequent tumor of mesothelial origin. This book provides readers with a better understanding of pleural diseases, their etiology, diagnosis, and therapy. 606 $aPleura$xDiseases 615 0$aPleura$xDiseases. 676 $a616.25 702 $aStojs?ic?$b Jelena 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910688330003321 996 $aDiseases of Pleura$92263339 997 $aUNINA